A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis
MUSD
1 other identifier
observational
6,000
1 country
1
Brief Summary
Improving the early diagnosis of breast cancer can reduce mortality. With mammography as the main tool for screening early breast cancer, the characteristics of dense breast and young onset of disease in Chinese women lowers the efficiency. The aim of this prospective study was to compare which method, x-ray or ultrasound, is more appropriate for screening and early diagnosis of breast cancer in Chinese women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2020
CompletedFirst Posted
Study publicly available on registry
June 12, 2020
CompletedStudy Start
First participant enrolled
June 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedJuly 9, 2020
July 1, 2020
3 years
June 10, 2020
July 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
screening yield
The sensitivity, specificity, positive predictive value, and negative predictive value of the screening methods.
3 years
Secondary Outcomes (1)
cost-effectiveness
3 years
Study Arms (1)
mammography and ultrasound
mammography and ultrasound screening
Interventions
Patients screened by both mammography and ultrasound.
Eligibility Criteria
Chinese female subjects aged 35-70 years who were asymptomatic and able to undergo ultrasound and X-rays
You may qualify if:
- Informed consent, subjects 35-70 years old, asymptomatic, able to undergo ultrasound and x-ray
You may not qualify if:
- Localized breast erythema and ulceration, pregnancy, lactation, after previous breast implantation, already pathologically definite breast cancer patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100730, China
Related Publications (2)
Wang Y, Li Y, Qu Y, Zhou Y, Sun Q, Shen S. Clinical and imaging characteristics of intraductal papillary neoplasms of the breast: a prospective trial. Discov Oncol. 2024 Dec 23;15(1):831. doi: 10.1007/s12672-024-01681-y.
PMID: 39715848DERIVEDWang Y, Li Y, Song Y, Chen C, Wang Z, Li L, Liu M, Liu G, Xu Y, Zhou Y, Sun Q, Shen S. Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial. Thorac Cancer. 2022 Nov;13(22):3145-3151. doi: 10.1111/1759-7714.14666. Epub 2022 Sep 30.
PMID: 36177910DERIVED
Biospecimen
Biopsy or specimen from volunteers or donors are planned to be collected
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Songjie Shen, MD
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and PUMC, BJ, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2020
First Posted
June 12, 2020
Study Start
June 12, 2020
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
July 9, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share
Individual information of each participant of the trials is not shown in public, yet can be obtained upon reasonable requirements.